source
- Amgen ends $500M Crohn’s disease collaboration with TScan, but TScan says pipeline strategy stays on trackAmgen has terminated its collaboration with TScan Therapeutics that was aimed at Crohn’s disease, ending a deal that could have delivered up to $500 million in milestones. The partnership began in…
- American Cancer Society cancels long-running alcohol industry gala amid optics concernsThe American Cancer Society announced it will not hold its annual Wine and Spirits Industry Gala that was scheduled for October at the Rainbow Room in Manhattan. The gala had been a major fundrais…